Jazz Pharmaceuticals Plc (JAZZ) Position Upped by Meiji Yasuda Asset Management Company Ltd; United Parcel Service (UPS) Market Valuation Rose While Dynamic Advisors Solutions Has Decreased Holding

August 12, 2018 - By Jack Shaw

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Logo

Dynamic Advisors Solutions Llc decreased its stake in United Parcel Service Inc (UPS) by 59.89% based on its latest 2018Q1 regulatory filing with the SEC. Dynamic Advisors Solutions Llc sold 9,884 shares as the company’s stock rose 6.87% while stock markets declined. The institutional investor held 6,619 shares of the transportation company at the end of 2018Q1, valued at $692,000, down from 16,503 at the end of the previous reported quarter. Dynamic Advisors Solutions Llc who had been investing in United Parcel Service Inc for a number of months, seems to be less bullish one the $102.61B market cap company. The stock decreased 1.32% or $1.6 during the last trading session, reaching $119.27. About 2.34 million shares traded. United Parcel Service, Inc. (NYSE:UPS) has risen 9.01% since August 12, 2017 and is uptrending. It has underperformed by 3.56% the S&P500. Some Historical UPS News: 05/04/2018 – Amazon and UPS have been quietly fighting over the post office’s cost structure – long before Trump; 15/03/2018 – SEMIRARA MINING AND POWER CORPORATION SCC.PS – UPS CAPITAL SPENDING BUDGET TO 13 BILLION PESOS; 26/04/2018 – UPS – FOR U.S. DOMESTIC SEGMENT IN 1Q 2018, OPERATING PROFIT INCLUDES HEADWINDS FROM SEVERE WINTER WEATHER OF $85 MLN; 26/04/2018 – More parcels, higher prices lift UPS profit but costs soar; 05/04/2018 – Pop-Ups Offer Classes on Today’s Hot Topics; 16/04/2018 – S&PGR Ups Red Hat To ‘BBB+’ On Strong Op Performance; Otll Stb; 20/03/2018 – Mint: Airbus is said to weigh new A330 cargo model, spurred by Amazon, UPS; 02/05/2018 – CNBC Wires: EXCLUSIVE-UPS SAYS SEEKING TO LAUNCH IN-HOME DELIVERY OPTION FOR BULKY GOODS; 21/03/2018 – S&PGR Ups Rocket Software To ‘B+’ On Better Metrics; Otlk Stbl; 06/03/2018 – UPS Names Operating Chief in Possible Step Toward CEO Succession

Meiji Yasuda Asset Management Company Ltd increased its stake in Jazz Pharmaceuticals Plc (JAZZ) by 111.11% based on its latest 2018Q1 regulatory filing with the SEC. Meiji Yasuda Asset Management Company Ltd bought 2,000 shares as the company’s stock rose 11.92% while stock markets declined. The institutional investor held 3,800 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $574,000, up from 1,800 at the end of the previous reported quarter. Meiji Yasuda Asset Management Company Ltd who had been investing in Jazz Pharmaceuticals Plc for a number of months, seems to be bullish on the $10.62B market cap company. The stock decreased 0.91% or $1.62 during the last trading session, reaching $176.11. About 393,069 shares traded. Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has risen 8.53% since August 12, 2017 and is uptrending. It has underperformed by 4.04% the S&P500. Some Historical JAZZ News: 08/05/2018 – Jazz Pharmaceuticals to settle U.S. probe for $57 million; 08/03/2018 – Jazz Pharma Closes Above 200-Day Moving Average: Technicals; 01/05/2018 – Jazz Pharmaceuticals Submits Supplemental New Drug Application for Xyrem® (sodium oxybate) to Treat Cataplexy and Excessive; 08/05/2018 – JAZZ PHARMA SEES FY ADJ EPS $12.75 TO $13.25, EST. $12.82; 25/05/2018 – Jazz Pharma Presenting at Conference Jun 5; 01/05/2018 – Jazz Pharmaceuticals Submits Supplemental New Drug Application for Xyrem® (sodium oxybate) to Treat Cataplexy and Excessive Da; 15/05/2018 – Partner Management Buys New 1.9% Position in Jazz Pharma; 15/05/2018 – Jazz Pharma Presenting at Bank of America Conference Tomorrow; 08/05/2018 – JAZZ PHARMACEUTICALS PLC SEES FULL YEAR 2018 GAAP NET INCOME PER DILUTED SHARE $6.60-$7.70; 01/05/2018 – Jazz Pharmaceuticals Submits Supplemental New Drug Application for Xyrem (sodium Oxybate)

Investors sentiment decreased to 1.12 in Q1 2018. Its down 0.11, from 1.23 in 2017Q4. It worsened, as 81 investors sold UPS shares while 390 reduced holdings. 111 funds opened positions while 418 raised stakes. 446.74 million shares or 0.46% less from 448.80 million shares in 2017Q4 were reported. Cooke Bieler LP owns 865,745 shares for 1.7% of their portfolio. Marathon Asset Llp reported 721,635 shares stake. Moreover, Palisade Asset Mngmt Ltd Liability has 0.24% invested in United Parcel Service, Inc. (NYSE:UPS). 7,460 are held by Daiwa Sb Limited. Hamilton Point Inv Advsrs Ltd has invested 0.94% in United Parcel Service, Inc. (NYSE:UPS). Partnervest Advisory Ltd Limited Liability Company holds 0.21% or 4,286 shares. Levin Strategies Lp reported 0.01% in United Parcel Service, Inc. (NYSE:UPS). Jefferies Group Ltd Liability Company invested 0.07% in United Parcel Service, Inc. (NYSE:UPS). The California-based Jacobs Ca has invested 1.43% in United Parcel Service, Inc. (NYSE:UPS). 120,000 were accumulated by Gyroscope Capital Mgmt Gru Limited Liability Com. Stanley invested 0.17% in United Parcel Service, Inc. (NYSE:UPS). Nelson Van Denburg Campbell Wealth Group Lc reported 8,393 shares. Moneta Grp Incorporated Invest Advisors Limited Liability Company reported 0.01% stake. Bangor Bancorp has invested 0.08% in United Parcel Service, Inc. (NYSE:UPS). City Holding Com holds 0.84% or 25,209 shares.

Among 24 analysts covering United Parcel Service (NYSE:UPS), 13 have Buy rating, 1 Sell and 10 Hold. Therefore 54% are positive. United Parcel Service had 78 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of United Parcel Service, Inc. (NYSE:UPS) earned “Buy” rating by S&P Research on Wednesday, July 29. The rating was maintained by Macquarie Research with “Neutral” on Wednesday, October 28. Robert W. Baird maintained United Parcel Service, Inc. (NYSE:UPS) on Thursday, October 5 with “Hold” rating. Deutsche Bank maintained the shares of UPS in report on Monday, January 8 with “Buy” rating. The firm has “Market Perform” rating by BMO Capital Markets given on Friday, October 27. The rating was maintained by Morgan Stanley on Monday, December 11 with “Sell”. JP Morgan initiated the shares of UPS in report on Tuesday, December 13 with “Neutral” rating. On Monday, December 4 the stock rating was upgraded by Deutsche Bank to “Buy”. The rating was downgraded by Deutsche Bank on Friday, February 23 to “Hold”. Robert W. Baird maintained the stock with “Hold” rating in Thursday, February 1 report.

Analysts await United Parcel Service, Inc. (NYSE:UPS) to report earnings on October, 25. They expect $1.82 earnings per share, up 25.52% or $0.37 from last year’s $1.45 per share. UPS’s profit will be $1.57B for 16.38 P/E if the $1.82 EPS becomes a reality. After $1.94 actual earnings per share reported by United Parcel Service, Inc. for the previous quarter, Wall Street now forecasts -6.19% negative EPS growth.

Dynamic Advisors Solutions Llc, which manages about $389.73M US Long portfolio, upped its stake in General Mls Inc (NYSE:GIS) by 33,953 shares to 46,520 shares, valued at $2.10 million in 2018Q1, according to the filing. It also increased its holding in Boeing Co (NYSE:BA) by 1,739 shares in the quarter, for a total of 5,299 shares, and has risen its stake in Alphabet Inc.

Since February 26, 2018, it had 0 buys, and 2 selling transactions for $650,730 activity. $480,600 worth of stock was sold by McClure Teri P on Monday, February 26.

More notable recent United Parcel Service, Inc. (NYSE:UPS) news were published by: Seekingalpha.com which released: “UPS Stalls Pre-Earnings Between Key Pivot Levels” on July 25, 2018, also Bizjournals.com with their article: “Online petition: ‘Demand’ that UPS add air conditioning to trucks” published on August 06, 2018, Benzinga.com published: “UPS Pilots Keyless Deliveries In New York City” on July 18, 2018. More interesting news about United Parcel Service, Inc. (NYSE:UPS) were released by: Seekingalpha.com and their article: “UPS lower after earnings” published on July 25, 2018 as well as Benzinga.com‘s news article titled: “Toys ‘R’ Us Bankruptcy Leaves Retailers Anxious To Pick Up The Slack” with publication date: August 09, 2018.

Since February 14, 2018, it had 0 insider purchases, and 23 selling transactions for $5.70 million activity. Another trade for 1,000 shares valued at $151,570 was sold by COZADD BRUCE C. On Thursday, June 14 the insider MILLER MICHAEL PATRICK sold $35,306. Young Matthew P. sold $163,998 worth of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) on Monday, March 5. The insider WILSON KAREN J sold 3,899 shares worth $604,345.

More notable recent Jazz Pharmaceuticals plc (NASDAQ:JAZZ) news were published by: Benzinga.com which released: “The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed’s Antibiotic Faces FDA Panel” on August 09, 2018, also Seekingalpha.com with their article: “Jazz reports late-stage trial for Vyxeos in blood cancer meets goal” published on July 19, 2018, Benzinga.com published: “The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos’ Maiden Earnings, Paratek Awaits Adcom Verdict” on August 08, 2018. More interesting news about Jazz Pharmaceuticals plc (NASDAQ:JAZZ) were released by: Benzinga.com and their article: “8 Stocks Moving In Tuesday’s After-Hours Session” published on August 07, 2018 as well as Benzinga.com‘s news article titled: “10 Biggest Price Target Changes For Wednesday” with publication date: August 08, 2018.

Among 24 analysts covering Jazz Pharmaceuticals (NASDAQ:JAZZ), 19 have Buy rating, 0 Sell and 5 Hold. Therefore 79% are positive. Jazz Pharmaceuticals had 90 analyst reports since August 3, 2015 according to SRatingsIntel. The company was maintained on Wednesday, February 24 by Stifel Nicolaus. RBC Capital Markets maintained the shares of JAZZ in report on Wednesday, November 8 with “Buy” rating. The stock of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has “Buy” rating given on Wednesday, October 18 by FBR Capital. Mizuho downgraded Jazz Pharmaceuticals plc (NASDAQ:JAZZ) on Tuesday, November 10 to “Neutral” rating. The firm earned “Buy” rating on Tuesday, July 10 by Citigroup. Piper Jaffray maintained it with “Buy” rating and $20100 target in Thursday, April 12 report. The firm earned “Buy” rating on Friday, October 9 by Mizuho. The stock of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has “Buy” rating given on Tuesday, August 29 by Cantor Fitzgerald. Mizuho maintained Jazz Pharmaceuticals plc (NASDAQ:JAZZ) on Tuesday, December 5 with “Hold” rating. As per Thursday, April 6, the company rating was downgraded by Mizuho.

Investors sentiment decreased to 1.02 in Q1 2018. Its down 0.07, from 1.09 in 2017Q4. It dropped, as 29 investors sold JAZZ shares while 96 reduced holdings. 44 funds opened positions while 84 raised stakes. 51.95 million shares or 1.94% less from 52.98 million shares in 2017Q4 were reported. Ledyard Bankshares owns 0% invested in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) for 75 shares. Regions Financial holds 85 shares. 1,660 were reported by Brave Asset Management Inc. Goldman Sachs Grp holds 732,200 shares. Thompson Mngmt stated it has 5,800 shares. Howe And Rusling Inc holds 606 shares or 0.02% of its portfolio. Eaton Vance Mgmt holds 0.04% of its portfolio in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) for 119,234 shares. Zurcher Kantonalbank (Zurich Cantonalbank) owns 175,166 shares. Advisory Svcs Limited reported 0% in Jazz Pharmaceuticals plc (NASDAQ:JAZZ). Senator Investment Grp Limited Partnership holds 2.69% or 1.50M shares in its portfolio. 27,111 were reported by Prelude Management. Bartlett Limited Co accumulated 550 shares. Moreover, Vanguard Gru Inc has 0.03% invested in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) for 4.79M shares. 2,947 are held by Fulton Bancorp Na. Strs Ohio owns 219,224 shares.

United Parcel Service, Inc. (NYSE:UPS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts